Press-release for stocks in the wholesale trade sector

Prices are updated after-hours

ABVC BioPharma Announces Vitargus Phase II Clinical Study Investigator Meeting
Published: 2022-04-26 (Crawled : 18:00) - globenewswire.com
ABVC | News | $1.015 -9.38% -10.34% 1.8M

| -56.6% | O: 0.0% H: 0.43% C: -4.68%
biopharma vitargus

| -65.18% | O: -3.32% H: 12.02% C: -7.73%
service metaverse technology software

56%

44%

INVO | $1.76 131.58% 56.82% 230M

SINT | $0.0365 59.39% 37.26% 470M

WISA 4 | $9.19 50.66% 33.7% 65M

EDBL | News | $6.73 47.91% 32.39% 13M

GCTK | $0.715 36.27% 26.62% 640K

TCON | $2.33 36.26% 26.61% 2M

TIRX | $0.48 6.43% 24.58% 4.8M

KZIA | $0.38 30.58% 23.42% 300K

VNDA | News | $5.23 29.14% 22.56% 24M

ATNF | $1.91 29.05% 22.51% 310K

Save your searches and get alerts when important news are released.